• 1. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 2. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

Recent Advances in the Application of 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carbaldehyde (CAS: 1367816-40-7) in Chemical Biology and Pharmaceutical Research

The compound 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carbaldehyde (CAS: 1367816-40-7) has recently emerged as a key building block in medicinal chemistry and drug discovery. This heterocyclic aldehyde derivative has shown significant potential in the synthesis of novel bioactive molecules, particularly in the development of kinase inhibitors and antimicrobial agents. Recent studies have highlighted its versatility as a synthetic intermediate due to the reactive aldehyde group and the bromine substituent, which allow for diverse functionalization strategies.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers utilized 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carbaldehyde as a starting material for the development of selective JAK3 inhibitors. The compound's pyrazole core served as an excellent scaffold for mimicking ATP-binding motifs in kinase domains, while the aldehyde functionality enabled efficient derivatization through reductive amination reactions. The resulting compounds demonstrated nanomolar potency against JAK3 with excellent selectivity profiles over other JAK family members.

Another significant application was reported in Bioorganic & Medicinal Chemistry Letters, where this compound was employed in the synthesis of novel antifungal agents. The bromine atom at the 4-position allowed for palladium-catalyzed cross-coupling reactions, enabling the introduction of various aryl and heteroaryl groups that enhanced antifungal activity against Candida species. Molecular docking studies revealed that these derivatives interact with fungal lanosterol 14α-demethylase, a key enzyme in ergosterol biosynthesis.

The physicochemical properties of 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carbaldehyde have also been extensively characterized in recent computational studies. Density functional theory (DFT) calculations have provided insights into its electronic structure and reactivity patterns, particularly regarding the electrophilicity of the aldehyde carbon and the influence of the bromine substituent on molecular orbital distributions. These computational models have proven valuable in predicting reactivity and guiding synthetic strategies.

From a safety and handling perspective, recent material safety data sheets (MSDS) updates have provided more detailed information about the compound's stability and storage requirements. While generally stable at room temperature, the aldehyde functionality makes it susceptible to oxidation, recommending storage under inert atmosphere at low temperatures for long-term preservation. The bromine substituent also necessitates careful handling due to potential lachrymatory effects.

Looking forward, the unique structural features of 4-Bromo-1,3-dimethyl-1H-pyrazole-5-carbaldehyde continue to inspire new applications in chemical biology. Current research directions include its incorporation into PROTAC (proteolysis targeting chimera) molecules and its use in DNA-encoded library synthesis. The compound's balanced lipophilicity and molecular weight make it particularly attractive for these emerging applications in drug discovery.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)